20010709
 Xenova Gets Approval To Start Clinical Trials For Vaccine for Cocaine   The Wall Street Journal,  Jul 10, 2001  LONDON (Reuters) -- British biotechnology company Xenova Group PLC said it won approval from U.S. regulators to resume clinical trials on a new vaccine to treat cocaine addiction.   
